This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2023.
Company Filing History:
1 out of 834,411 Years Active: 2023
Title: Sheeba Wajid: Innovator in Alzheimer's Research
Introduction
Sheeba Wajid is a prominent inventor based in Karachi, Pakistan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating Alzheimer's Disease. Her innovative work focuses on the inhibition of the butyrylcholinesterase enzyme, which is associated with cognitive decline in Alzheimer's patients.
Latest Patents
Sheeba Wajid holds a patent for "Derivatives of 4-aminoantipyrine as anti-Alzheimer's butyrylcholinesterase inhibitors." This invention involves the treatment of diseases linked to increased butyrylcholinesterase enzyme activity, specifically Alzheimer's Disease. The patent details the administration of effective amounts of new N, N'-disubstituted benzylamine derivatives of 4-aminoantipyrine. Kinetic studies of two potent compounds revealed their potential as competitive and non-competitive inhibitors of butyrylcholinesterase.
Career Highlights
Throughout her career, Sheeba has demonstrated a commitment to advancing medical research. Her work has not only contributed to the understanding of Alzheimer's Disease but also provided new avenues for treatment. She continues to explore innovative solutions in the field of pharmacology.
Collaborations
Sheeba Wajid collaborates with talented individuals such as Hina Siddiqui and Atia-tul-Wahab. These partnerships enhance her research efforts and contribute to the development of effective therapeutic strategies.
Conclusion
Sheeba Wajid's contributions to Alzheimer's research exemplify her dedication to innovation in medicinal chemistry. Her patent on butyrylcholinesterase inhibitors represents a significant step forward in the fight against Alzheimer's Disease.